|
CARDIAC SCIENCE
SETTLES PATENT INFRINGEMENT SUIT WITH SMALLER COMPETITOR
$925,000 Payment to Cardiac Science Settles Dispute
IRVINE, Calif., (August 9, 2005)…Cardiac Science, Inc. (Nasdaq: DFIB),
a leading manufacturer of life-saving automatic public-access
defibrillators (AEDs), announced today that it has settled its
patent infringement lawsuit it had brought against privately-held
Defibtech, L.L.C. in the United States District Court for the
District of Minnesota in April, 2003. As a condition of settlement,
Cardiac Science will receive a cash payment in the amount of
$925,000.
Cardiac Science’s allegations of infringement by Defibtech of United
States Patent No.’s 5,579,919, 5,700,281 and 6,038,473 and all of
Defibtech’s assorted counterclaims have been fully resolved. Other
terms and conditions of the settlement remain confidential.
Cardiac Science’s Chairman and CEO Raymond W. Cohen said, "This
settlement further demonstrates the strength of our patent portfolio
and serves as yet another example where Cardiac Science has
prevailed when our intellectual property assets were threatened by a
competitor. We will continue to be vigilant in the marketplace in
defending our inventions. And as our track record demonstrates, when
necessary, we will not shy away from seeking remedy in court in
order to dissuade our competitors, irrespective of their size or
standing in the marketplace, from inappropriately employing our
patented AED features and technology. To that end, we fully intend
to continue to aggressively pursue the outstanding patent litigation
suit which we brought against Philips in early 2003 until it is
resolved to our satisfaction and we receive sufficient recompense.”
<< terug naar het
overzicht >>
>>
Gratis:
Demonstratie op locatie aanvragen
>>
Offerte aanvragen van alle
verkrijgbare toestellen
|
